Objective: We conducted this study to detect the prevalence, incidence, and risk factors of hypertension in Taiwanese patients with major depressive disorder (MDD).
Methods: The National Health Research Institute provided a database of 1,000,000 random subjects for study. We obtained a random sample of 766,427 subjects, aged ≥18 years in 2005. Study subjects had at least one service claim during 2005 for either outpatient or inpatient care with a primary diagnosis of MDD or with a primary or secondary diagnosis of hypertension and combined with antihypertensive drug treatment were identified. We also compared the incidence of hypertension among patients with MDD and the general population from 2006 through 2008.
Results: The 1-year prevalence of hypertension in patients with MDD was higher than that in the general population (21.21% vs. 13.28%, risk ratio, 1.22; 95% confidence interval, 1.17-1.28). Compared with the general population, patients with MDD had a higher prevalence of hypertension in all age, sex, insurance amount, region, and urbanicity groups. The average annual incidence of hypertension in patients with MDD from 2006 to 2008 was higher than that in the general population (3.96% vs. 2.90%, risk ratio, 1.19; 95% confidence interval, 1.08-1.31). Compared with the general population, patients with MDD had a higher incidence of hypertension in all age, and male groups.
Conclusions: Patients with MDD had a higher prevalence and a higher incidence of hypertension than that in the general population. Age, male gender, and antipsychotic use were risk factors for hypertension among patients with MDD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jpsychores.2012.07.002 | DOI Listing |
Sensors (Basel)
January 2025
University of Zagreb Faculty of Electrical Engineering and Computing, Unska 3, 10000 Zagreb, Croatia.
Major depressive disorder (MDD) is associated with substantial morbidity and mortality, yet its diagnosis and treatment rates remain low due to its diverse and often overlapping clinical manifestations. In this context, electroencephalography (EEG) has gained attention as a potential objective tool for diagnosing depression. This study aimed to evaluate the effectiveness of EEG in identifying MDD by analyzing 140 EEG recordings from patients diagnosed with depression and healthy volunteers.
View Article and Find Full Text PDFJ ECT
January 2025
From the Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA.
Background: Electroconvulsive therapy (ECT) is an effective treatment for treatment-resistant depression (TRD). There are limited data on the improvement of anxiety symptoms in patients receiving ECT for TRD.
Objective: The aim of the study was to examine the extent to which anxiety symptom severity improves, relative to improvements in depressive symptoms, in TRD patients receiving an acute course of ECT.
Circ Cardiovasc Interv
January 2025
Division of Cardiology, Department of Medicine, University of Washington Medical Center, Seattle (E.J.S., T. Salahuddin, J.A.D.).
Background: Intravascular imaging (IVI) is widely recognized to improve outcomes after percutaneous coronary intervention (PCI). However, IVI is underutilized and is not yet established as a performance measure for quality PCI.
Methods: We examined temporal trends of IVI use for all PCIs performed at Veterans Affairs hospitals in the United States from 2010 to 2022 using retrospective observational cohorts.
Front Psychiatry
January 2025
Department of Psychiatry, Korea University College of Medicine, Seoul, Republic of Korea.
Background: Stress is a significant risk factor for psychiatric disorders such as major depressive disorder (MDD) and panic disorder (PD). This highlights the need for advanced stress-monitoring technologies to improve treatment. Stress affects the autonomic nervous system, which can be evaluated via heart rate variability (HRV).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!